Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 6 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Malnutrition 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Lung Neoplasms 2 Locally Advanced Head and Neck Carcinoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Wilms Tumor 1 Surgery--Complications 1 Sarcoma 1 Prostatic Intraepithelial Neoplasia 1 Peripheral Nervous System Diseases 1 Peptic Ulcer 1 Nutrition Related Cancer 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nasopharyngeal Carcinoma 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Motor Activity 1 Malabsorption Syndromes 1

Interventions

Oxaliplatin 18 Surveys and Questionnaires 15 Fluorouracil 15 Capecitabine 13 Leucovorin 12 Blood Specimen Collection 11 Irinotecan 10 Standard of Care 7 Cisplatin 7 Endoscopic Mucosal Resection 6 atezolizumab 5 Specimen Handling 5 Radiotherapy 5 Educational Status 5 Drug Therapy 5 Docetaxel 5 S 1 (combination) 4 Radiosurgery 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Interviews as Topic 4 Gemcitabine 4 Everolimus 4 Colonoscopy 4 Biopsy 4 Bevacizumab 4 tegafur-gimeracil-oteracil 3 pemigatinib 3 apatinib 3 Remote Patient Monitoring 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gastrointestinal Neoplasms × Dietary Supplements × Clear all

NCT03445260 2021-09-02

PROGRESS

Hamilton Health Sciences Corporation

Phase NA Completed

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡